Sensus Healthcare, Inc. (NASDAQ:SRTS) Sees Large Decrease in Short Interest
Sensus Healthcare, Inc. (NASDAQ:SRTS) Sees Large Decrease in Short Interest
Sensus Healthcare, Inc. (NASDAQ:SRTS – Get Rating) saw a significant decrease in short interest in the month of July. As of July 31st, there was short interest totalling 305,000 shares, a decrease of 22.9% from the July 15th total of 395,500 shares. Based on an average trading volume of 232,700 shares, the short-interest ratio is presently 1.3 days. Currently, 2.6% of the company's shares are short sold.
人口普查保健公司(納斯達克：SRTS-GET Rating)看到空頭股數在7月份出現了顯著下降。截至7月31日，空頭股數共有30.5萬股，比7月15日的39.55萬股減少了22.9%。以平均成交量232,700股計算，目前短息比率為1.3天。目前，該公司2.6%的股票被賣空。
Wall Street Analyst Weigh In
華爾街分析師也加入進來
Separately, Maxim Group reissued a "buy" rating and issued a $14.00 target price on shares of Sensus Healthcare in a report on Friday, May 6th.
另外，Maxim Group在5月6日(星期五)的一份報告中重新發布了“買入”評級，併發布了Scount Healthcare股票的目標價14.00美元。
Insider Buying and Selling
內幕買賣
In other news, CEO Joseph C. Sardano sold 36,093 shares of Sensus Healthcare stock in a transaction on Tuesday, August 9th. The shares were sold at an average price of $13.97, for a total transaction of $504,219.21. Following the completion of the sale, the chief executive officer now directly owns 1,294,200 shares of the company's stock, valued at approximately $18,079,974. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other news, CEO Joseph C. Sardano sold 36,093 shares of the company's stock in a transaction on Tuesday, August 9th. The shares were sold at an average price of $13.97, for a total transaction of $504,219.21. Following the transaction, the chief executive officer now directly owns 1,294,200 shares of the company's stock, valued at approximately $18,079,974. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Joseph C. Sardano sold 28,999 shares of the company's stock in a transaction dated Thursday, August 11th. The shares were sold at an average price of $14.21, for a total transaction of $412,075.79. Following the completion of the sale, the chief executive officer now directly owns 1,171,881 shares in the company, valued at approximately $16,652,429.01. The disclosure for this sale can be found here. Over the last three months, insiders sold 75,114 shares of company stock worth $1,056,202. Company insiders own 16.36% of the company's stock.
在其他新聞方面，首席執行官約瑟夫·C·薩達諾在8月9日(星期二)的一筆交易中出售了36,093股Scount Healthcare股票。這些股票以13.97美元的平均價格出售，總成交金額為504,219.21美元。出售完成後，首席執行官現在直接擁有1,294,200股公司股票，價值約18,079,974美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，該文件可通過美國證券交易委員會網站獲得。另一則消息是，首席執行官約瑟夫·C·薩達諾在8月9日星期二的一次交易中出售了36,093股公司股票。這些股票以13.97美元的平均價格出售，總成交金額為504,219.21美元。交易完成後，這位首席執行官現在直接擁有1,294,200股公司股票，價值約18,079,974美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，可以通過美國證券交易委員會網站訪問該文件。此外，首席執行官約瑟夫·C·薩達諾在日期為8月11日(星期四)的交易中出售了28,999股公司股票。這些股票以14.21美元的平均價格出售，總成交額為412,075.79美元。出售完成後，首席執行官現在直接擁有公司1,171,881股，價值約16,652,429.01美元。此次拍賣的披露信息可在此處找到。在過去三個月裏，內部人士出售了75,114股公司股票，價值1,056,202美元。公司內部人士持有該公司16.36%的股份。
Institutional Trading of Sensus Healthcare
人口普查醫療的制度性交易
Sensus Healthcare Stock Performance
人口普查醫療保健股票表現
Shares of SRTS stock opened at $14.97 on Friday. Sensus Healthcare has a twelve month low of $3.21 and a twelve month high of $15.25. The company has a market capitalization of $249.70 million, a price-to-earnings ratio of 9.91 and a beta of 0.78. The stock's 50 day simple moving average is $9.63 and its 200 day simple moving average is $9.29.
SRTS股票上週五開盤報14.97美元。Scount Healthcare的12個月低點為3.21美元，12個月高位為15.25美元。該公司市值為2.497億美元，市盈率為9.91倍，貝塔係數為0.78。該股的50日簡單移動均線切入位為9.63美元，200日簡單移動均線切入位為9.29美元。
Sensus Healthcare Company Profile
Scount Healthcare公司簡介
(Get Rating)
(獲取評級)
Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.
Scount Healthcare，Inc.是一家醫療設備公司，向世界各地的醫療保健提供者製造和銷售放射治療設備。該公司在其治療設備組合中使用了表面放射治療(SRT)，這是一種低能X射線技術。它提供SRT-100，這是一種光子X射線低能量表面放射治療系統，為患者提供治療非黑色素瘤皮膚癌，包括基底細胞和鱗狀細胞皮膚癌，以及瘢痕疙瘩等其他皮膚疾病的替代手術；以及SRT-100 Vision，為用户提供SRT量身定製的治療計劃應用程序，其中集成了嵌入式高頻超聲成像模塊、體積腫瘤分析、束流邊緣規劃和劑量學參數。
Featured Articles
專題文章
- Get a free copy of the StockNews.com research report on Sensus Healthcare (SRTS)
- MarketBeat: Week in Review 8/8 – 8/12
- 2 Important Retail Stock Battles to Watch
- What Is WallStreetBets and What Stocks Are They Targeting?
- Institutions And Analysts Propel Jack In The Box Higher
- Can You Guess Which EV Stock Is Beating Tesla ?
- 免費獲取StockNews.com關於人口普查醫療保健(SRTS)的研究報告
- MarketBeat：回顧中的一週2012-8-8
- 值得關注的兩場重要的零售股大戰
- 什麼是WallStreetBets，他們的目標是什麼股票？
- 機構和分析師推動Jack in the Box走高
- 你能猜到哪個電動車股票打敗了特斯拉嗎？
Receive News & Ratings for Sensus Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensus Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
接收人口普查和醫療保健日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收最新新聞和分析師對Scount Healthcare及相關公司評級的每日摘要。
譯文內容由第三人軟體翻譯。